About the job
About Us
Be Part of the Robotic Biomanufacturing Revolution!
Multiply Labs is at the forefront of robotics innovation, dedicated to addressing a critical challenge in modern medicine: the automated production of life-saving advanced biologics, including gene therapies, cell therapies, antibodies, and more.
Currently, these essential therapies are created using manual and labor-intensive methods, resulting in exorbitant costs—often between $500K and $2M per patient—restricting access for many who need them.
As the complexity of products grows and the stakes of failure and scientific labor escalate, the industry is increasingly turning to automation. Robotics and AI are paving the way for a future where biologics manufacturing is feasible, dependable, and economically scalable.
We envision a future where biomanufacturing is robotic, closed, automated, and scalable—guaranteeing that vital therapeutics are available to every patient in need.
Why This Matters
We aren’t just manufacturing robots—we’re creating the essential infrastructure for the next generation of biologics. Our technology empowers biopharma companies to scale production seamlessly without altering their scientific foundations, minimizing regulatory obstacles and reducing costs, thereby expanding access to these treatments.
The Stack & The Scale
The Mission: Craft the world’s finest robots to ensure life-saving therapies are accessible to all.

